Cancer Cell Metabolism: One Hallmark, Many Faces

被引:727
作者
Cantor, Jason R. [1 ,2 ]
Sabatini, David M. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA
[3] Koch Inst Integrat Canc Res, Cambridge, MA USA
[4] MIT, Howard Hughes Med Inst, Cambridge, MA USA
[5] MIT, Dept Biol, Cambridge, MA USA
关键词
PYRUVATE-KINASE M2; ACUTE LYMPHOBLASTIC-LEUKEMIA; L-ASPARAGINASE RESISTANCE; GLUTAMINE-METABOLISM; FATTY-ACID; C-MYC; TUMOR MICROENVIRONMENT; ALPHA-KETOGLUTARATE; GLUCOSE-METABOLISM; AEROBIC GLYCOLYSIS;
D O I
10.1158/2159-8290.CD-12-0345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer cells must rewire cellular metabolism to satisfy the demands of growth and proliferation. Although many of the metabolic alterations are largely similar to those in normal proliferating cells, they are aberrantly driven in cancer by a combination of genetic lesions and nongenetic factors such as the tumor microenvironment. However, a single model of altered tumor metabolism does not describe the sum of metabolic changes that can support cell growth. Instead, the diversity of such changes within the metabolic program of a cancer cell can dictate by what means proliferative rewiring is driven, and can also impart heterogeneity in the metabolic dependencies of the cell. A better understanding of this heterogeneity may enable the development and optimization of therapeutic strategies that target tumor metabolism.
引用
收藏
页码:881 / 898
页数:18
相关论文
共 159 条
  • [1] IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
    Amary, M. Fernanda
    Bacsi, Krisztian
    Maggiani, Francesca
    Damato, Stephen
    Halai, Dina
    Berisha, Fitim
    Pollock, Robin
    O'Donnell, Paul
    Grigoriadis, Anita
    Diss, Tim
    Eskandarpour, Malihe
    Presneau, Nadege
    Hogendoorn, Pancras C. W.
    Futreal, Andrew
    Tirabosco, Roberto
    Flanagan, Adrienne M.
    [J]. JOURNAL OF PATHOLOGY, 2011, 224 (03) : 334 - 343
  • [2] Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
    Anastasiou, Dimitrios
    Poulogiannis, George
    Asara, John M.
    Boxer, Matthew B.
    Jiang, Jian-kang
    Shen, Min
    Bellinger, Gary
    Sasaki, Atsuo T.
    Locasale, Jason W.
    Auld, Douglas S.
    Thomas, Craig J.
    Vander Heiden, Matthew G.
    Cantley, Lewis C.
    [J]. SCIENCE, 2011, 334 (6060) : 1278 - 1283
  • [3] Asparaginase Kurtzberg J., 2000, CANC MED, P699
  • [4] Atsumi T, 2002, CANCER RES, V62, P5881
  • [5] Avramis VI, 2006, INT J NANOMED, V1, P241
  • [6] 18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
    Ben-Haim, Simona
    Ell, Peter
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) : 88 - 99
  • [7] TIGAR, a p53-inducible regulator of glycolysis and apoptosis
    Bensaad, Karim
    Tsuruta, Atsushi
    Selak, Mary A.
    Calvo Vidal, M. Nieves
    Nakano, Katsunori
    Bartrons, Ramon
    Gottlieb, Eyal
    Vousden, Karen H.
    [J]. CELL, 2006, 126 (01) : 107 - 120
  • [8] The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
    Berwick, DC
    Hers, I
    Heesom, KJ
    Moule, SK
    Tavaré, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) : 33895 - 33900
  • [9] Bluemlein K, 2011, ONCOTARGET, V2, P393
  • [10] Cairns RA, 2012, COLD SPRING HARB SYM, V76, P299